Preclinical literature demonstrates that the plasma melanotan 2 half life is approximately 1 to 2 hours, though downstream receptor activation and cell signaling can persist significantly longer. PX1 Research supplies high-purity, USA-synthesized Melanotan 2 (MT-II) accompanied by lot-specific HPLC/MS and endotoxin COAs, dispatched same-day M–F from California and Arizona facilities.
Preclinical literature demonstrates that the plasma melanotan 2 half life is approximately 1 to 2 hours, though downstream receptor activation and cell signaling can persist significantly longer. PX1 Research supplies high-purity, USA-synthesized Melanotan 2 (MT-II) accompanied by lot-specific HPLC/MS and endotoxin COAs, dispatched same-day M–F from California and Arizona facilities.
In preclinical animal models and in vitro plasma stability assays, Melanotan 2 exhibits an elimination half-life of roughly 60 to 120 minutes. This relative brevity in circulation is driven by hepatic cleavage and renal clearance mechanisms characteristic of small synthetic cyclic peptides.
However, plasma elimination does not directly mirror receptor occupancy time. Because MT-II binds with high affinity to melanocortin receptors (MC1R, MC3R, MC4R, and MC5R), secondary intracellular messenger cascades—such as cAMP accumulation—can remain active long after active peptide concentrations decline in surrounding media.
When designing in vitro or animal models, investigators must differentiate between initial peptide clearance rates and sustained biological effector duration. Utilizing high-purity reagents verified by mass spectrometry ensures that kinetic measurements reflect pure peptide behavior rather than degradation artifacts.
Melanotan 2 (MT-II) is a synthetic cyclic lactam analog of the naturally occurring endogenous peptide alpha-melanocyte-stimulating hormone (α-MSH). Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, it features a bridge structure engineered to resist enzymatic breakdown while maintaining high binding affinity across multiple melanocortin receptor subtypes.
As a non-selective melanocortin analog, melanotan ii exhibits high agonist activity at MC1R, MC3R, MC4R, and MC5R. In preclinical studies, it is primarily researched for melanocortin activity related to skin pigmentation responses, melanogenesis pathways, and central energy homeostasis pathways.
Understanding receptor dynamics requires standardized, unadulterated peptide samples. Researchers evaluating binding kinetics can order 10 mg vials of MT-II with full analytical verification to ensure reproducible assay outcomes.
Pharmacokinetic evaluations in rodent models indicate that the primary terminal elimination melanotan 2 half life ranges between 1.0 and 2.2 hours following systemic delivery. The rapid initial distribution phase occurs within minutes, followed by a steady bi-exponential elimination phase.
While the intact peptide is cleared from systemic circulation within a few hours, preclinical models observing melanocyte activation note biological activity lasting up to 24 to 36 hours. This disconnect between plasma elimination and functional response is attributed to slow receptor dissociation rates and durable intracellular signaling events.
In contrast to native α-MSH—which possesses a half-life measured in minutes due to rapid cleavage by serum proteases—the synthetic modifications in mt2 drastically extend both systemic persistence and receptor activation thresholds.
The metabolic stability of Melanotan 2 is primarily determined by its cyclic ring structure and specific amino acid substitutions. The incorporation of D-phenylalanine at position 7 (D-Phe7) and norleucine at position 4 (Nle4) protects the peptide from immediate recognition by endopeptidases.
Despite these stabilizing modifications, MT-II does not utilize long-acting extended technologies such as fatty-acid acylation or a Dipeptidyl Peptidase-4 (DPP-4) resistant backbone seen in modern metabolic peptides. Consequently, renal filtration remains the dominant primary clearance pathway for intact and partially cleaved fragments.
Enzymatic metabolism occurs primarily via slow hydrolysis of peptide bonds outside the protected cyclic core. Because hepatic endopeptidases eventually degrade these residues, clearance is predictable and unencumbered by prolonged tissue accumulation.
In cell culture environments, understanding the active half-life of mt2 is critical for establishing effective media replacement cycles and stimulus intervals. In serum-containing culture media, thermal denaturation and serum peptidases degrade the peptide at rates comparable to in vivo plasma clearance.
For cyclic adenosine monophosphate (cAMP) accumulation assays, exposure times of 30 to 60 minutes are generally sufficient to achieve peak signal generation. Extending incubation periods beyond 4 hours without refreshing the media may yield diminished signaling due to cumulative enzymatic degradation.
Researchers conducting prolonged stimulation studies on melanocyte cell lines often utilize pulse-treatment protocols or periodic media replenishment every 12 to 24 hours to maintain receptor engagement without subjecting cultures to excessive baseline degradation products.
Comparing MT-II against structural analogues provides insight into how chemical modifications alter metabolic half-life and receptor selectivity. Native α-MSH has an extremely short plasma half-life of under 10 minutes, making it impractical for long-duration baseline assays without continuous infusion.
Afamelanotide (NDP-α-MSH), a linear counterpart, displays a slightly longer plasma elimination profile (~30 to 45 minutes) but relies on high-affinity binding to sustain biological effects. Bremelanotide (PT-141), a metabolite derivative lacking the N-terminal acetyl group of MT-II, displays similar terminal elimination parameters in rodent models (~1.5 to 2 hours) while shifting receptor preference toward MC3R and MC4R.
For comparative studies across the melanocortin class, researchers can review our complete collection of research peptides or explore specific analogs like Bremelanotide PT-141 to evaluate differences in half-life and target receptor profiles.
Accurate half-life determinations depend entirely on reagent purity. Contaminants such as truncated sequence fragments or counter-ion residues can alter degradation rates in serum assays or interfere with HPLC detection.
When sourcing peptides for quantitative pharmacokinetic research, evaluate suppliers using these explicit structural criteria:
Purity Verification: Must be minimum 98% confirmed via high-performance liquid chromatography (HPLC).
Sequence Identity: Verified via electrospray ionization mass spectrometry (ESI-MS) matching precise molecular weight (1024.2 g/mol).
Endotoxin Data: Bacterial endotoxin content below 0.01 EU/mg to prevent inflammatory artifact interference in cell assays.
Lot Traceability: Every vial assigned a unique batch identifier linked to a live, publicly accessible Certificate of Analysis.
Shipping & Handling: Lyophilized storage with temperature-controlled transit to prevent pre-assay thermal degradation.
Inaccurate half-life measurements and conflicting assay results frequently stem from sub-standard reference materials. Researchers should exercise caution when evaluating vendor documentation for research chemicals.
Red flags include generalized COAs that lack lot-specific batch numbers, missing mass spectrometry spectrum graphs, or ambiguous assay purity ratings without corresponding peak integration tables.
Furthermore, suppliers that fail to publish endotoxin levels pose a significant risk to cell viability assays. High endotoxin content alters cell membrane permeability and receptor expression, obscuring true peptide half-life and kinetic data.
PX1 Research provides high-grade, USA-synthesized Melanotan 2 designed specifically for rigorous laboratory and in vitro evaluation. Each batch undergoes rigorous testing to guarantee exact sequence fidelity and analytical purity.
When you buy from PX1 Research, your order ships in sealed, vacuum-packed 10 mg lyophilized vials engineered for optimal reconstitution stability. Orders placed before 3:00 PM PST dispatch same-day from our California and Arizona logistics hubs via tracked domestic courier.
To review full lot-specific testing data or procure reagents for your research facility, visit the live product page to buy Melanotan 2 10mg vials or consult our scientific research library for comparative technical specifications.
What is the reported melanotan 2 half life in animal models?
Preclinical animal studies report a plasma elimination half-life for Melanotan 2 of approximately 1 to 2 hours. However, receptor-mediated biological effects, such as downstream signal transduction, often persist up to 24 to 36 hours due to strong receptor binding affinity.
How does the half-life of mt2 compare to native alpha-MSH?
Native alpha-MSH has a plasma half-life of less than 10 minutes due to rapid cleavage by serum peptidases. The synthetic cyclic structure of mt2 grants superior enzymatic stability, extending its clearance half-life to roughly 1 to 2 hours.
Why does melanotan ii display longer biological activity than its plasma half-life suggests?
Melanotan ii binds tightly to melanocortin receptors (MC1R/MC4R), inducing intracellular intracellular signaling cascades (cAMP accumulation) that remain active long after the free peptide has cleared from the surrounding plasma or cell culture medium.
What clearance pathways eliminate Melanotan 2 from biological systems?
Melanotan 2 is cleared primarily via renal filtration of intact and partially degraded fragments, alongside minor enzymatic cleavage by hepatic and systemic peptidases targeting non-cyclic peptide bonds.
How should researchers account for half-life in cell culture assay protocols?
Because MT-II degrades in serum-supplemented media within a few hours, long-term cell assays should refresh the media every 12 to 24 hours or utilize short, timed-pulse exposures to measure immediate receptor activation dynamics.
Is Melanotan 2 stable in reconstituted aqueous solution?
When reconstituted in sterile bacteriostatic water or buffered saline, lyophilized MT-II remains stable at 2°C to 8°C for several weeks. However, freeze-thaw cycles should be avoided to prevent structural degradation.
How does cyclic structure influence the metabolic stability of MT-II?
The lactam bridge in cyclic peptides restricts conformational flexibility, preventing exopeptidases and endopeptidases from easily accessing the peptide backbone and significantly lengthening degradation time relative to linear peptides.
Does PX1 Research provide lot-specific COAs for Melanotan 2?
Yes. Every lot of Melanotan 2 supplied by PX1 Research includes a accessible, lot-specific Certificate of Analysis detailing HPLC purity, mass spectrometry weight confirmation, and quantitative endotoxin testing results.
How fast does PX1 Research ship Melanotan 2 orders?
Orders placed before 3:00 PM PST Monday through Friday ship same-day from California or Arizona distribution centers, arriving at domestic laboratories within 1 to 3 business days via tracked expedited shipping.
What peptide purity level is required for melanocortin receptor research?
Preclinical assays require a minimum of 98% analytical purity verified via HPLC to prevent baseline interference, receptor cross-reactivity, or toxic cellular artifacts caused by synthesis side-products.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.